Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

FDA approves Niaspan for the treatment of mixed lipid disorders

July 30, 1997

Research Triangle Institute investigates compounds for male fertility control

July 30, 1997

Vivus launches new device for erectile dysfunction in the U.S.

July 29, 1997

Papaverine/phentolamine compared to PGE1 for erectile dysfunction

July 29, 1997

Unigene Laboratories and Parke-Davis to develop oral calcitonin for osteoporosis

July 29, 1997

Statins protect against stroke and CVD

July 29, 1997

Potential alternative for long-term treatment of obesity

July 28, 1997

BioTime's Hextend enters European clinical trials; licensed to Abbott

July 28, 1997

Forbes Medi-Tech submits patent, reports on clinical trials

July 28, 1997

New approaches to the pharmacological treatment of obesity

July 25, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...